what they said (Hover the mouse cursor over underlined words for more info)

Men may also benefit from a vaccine designed to protect women from cervical cancer, researchers said Thursday.

The Gardasil vaccine was 90 per cent effective in preventing lesions such as sexually transmitted warts that are not life-threatening, according to the placebo-controlled study of 4,000 males that was funded by the vaccine's manufacturer and presented at a medical conference in Nice, France...

The original article can be found at: http://www.cbc.ca/health/story/2008/11/13/hpv-vaccine-men.html?ref=rss

how did it rate? (more information)

what we said (Hover the mouse cursor over underlined words for more info)

Despite the inclusion of some really important pieces of information including adequate details of the study design and the quantification of both treatment benefits and harms, the most prominent issue with this article was that it did not mention the existence of the HPV strains that are virtually unaffected by the vaccine. Distinguishing these strains is important for clarifying that this vaccine should not be accepted as a blanket treatment for all cases of HPV. A discussion of alternative treatment options might have been easily accompanied by a description of the different HPV strains. This discussion would hopefully clarify the precise strain under investigation in this research and allow readers to be more fully informed about the restrictions of this treatment option.

public forum

voice your opinion in the forum

• All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
• If you provide your email address it will not be displayed to the general public.
• Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
• Required fields are marked with an asterisk (*).